Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study

A. He; J. Valle; C. Lee; M. Ikeda; P. Potemski; C. Morizane; J. Cundom; D. Tougeron; F. Dayyani; N. Rokutanda; J. Xiong; G. Cohen; D. Oh

doi:10.1016/j.annonc.2022.04.442

YUHSpace

BROWSE

0 230

Cited 0 times in

Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study

Authors: A. He ; J. Valle ; C. Lee ; M. Ikeda ; P. Potemski ; C. Morizane ; J. Cundom ; D. Tougeron ; F. Dayyani ; N. Rokutanda ; J. Xiong ; G. Cohen ; D. Oh